histosonics.comHealthcare / Medical DevicesFounded: 2009Funding to Date: $308.72MM
HistoSonics is a medical device and robotics company specializing in radiology and non-invasive surgical technology. With a mission to bring meaningful change to the lives of patients with non-invasive surgery, the company aims to use advanced scientific techniques of histotripsy in medical facilities across the globe. HistoSonics was founded by Brian Fowlkes, M. Christine Gibbons, and Thomas Davison in 2009 and is headquartered in Plymouth, Minnesota.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
08/15/2024 | Series D-1 | $102.7MM | $xx.xx | $598.27MM | Alpha Wave Ventures, Amzak Health, Healthquest Capital, Johnson & Johnson Innovation, Lumira Ventures, Venture Investors, Wisconsin Investment Board, Yonjin Venture | |
Price per Share
$xx.xx
Shares Outstanding
64,376,608
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Cumulative
Participating
Participating
Participation Cap
1000
Key Investors
Alpha Wave Ventures, Amzak Health, Healthquest Capital, Johnson & Johnson Innovation, Lumira Ventures, Venture Investors, Wisconsin Investment Board, Yonjin Venture
|
||||||
12/12/2022 | Series D-2 | $85MM | $xx.xx | $487.79MM | Johnson & Johnson Innovation, Lumira Ventures, Venture Investors, Wisconsin Investment Board, Yonjin Venture | |
Price per Share
$xx.xx
Shares Outstanding
59,200,446
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Cumulative
Participating
Participating
Participation Cap
1000
Key Investors
Johnson & Johnson Innovation, Lumira Ventures, Venture Investors, Wisconsin Investment Board, Yonjin Venture
|
||||||
04/15/2020 | Series C-1 | $40.76MM | $xx.xx | $279.68MM | Johnson & Johnson Innovation, Lumira Ventures, Varian Medical Systems, Venture Investors, Wisconsin Investment Board, Yonjin Venture | |
Price per Share
$xx.xx
Shares Outstanding
42,828,469
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Cumulative
Participating
Participating
Participation Cap
1000
Key Investors
Johnson & Johnson Innovation, Lumira Ventures, Varian Medical Systems, Venture Investors, Wisconsin Investment Board, Yonjin Venture
|
||||||
04/05/2019 | Series C | $54MM | $xx.xx | $222.19MM | Fred Moll, Johnson & Johnson Innovation, Lumira Ventures, Varian Medical Systems, Venture Investors, Wisconsin Investment Board | |
Price per Share
$xx.xx
Shares Outstanding
82,493,126
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
7.9%
Cumulative
Cumulative
Participating
Participating
Participation Cap
1000
Key Investors
Fred Moll, Johnson & Johnson Innovation, Lumira Ventures, Varian Medical Systems, Venture Investors, Wisconsin Investment Board
|
||||||
03/13/2017 | Series B | $12.09MM | $xx.xx | $66.08MM | Early Stage Partners, Fletcher Spaght Ventures, Grand Angels, Hatteras Venture Partners, Michigan Investment in New Technology Startups, Tgap Ventures, Venture Investors, Wolverine Venture Fund | |
Price per Share
$xx.xx
Shares Outstanding
22,134,273
Liquidation Pref Order
3
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.1%
Cumulative
Cumulative
Participating
Participating
Participation Cap
1000
Key Investors
Early Stage Partners, Fletcher Spaght Ventures, Grand Angels, Hatteras Venture Partners, Michigan Investment in New Technology Startups, Tgap Ventures, Venture Investors, Wolverine Venture Fund
|
||||||
12/16/2009 | Series A | $14.17MM | $xx.xx | $56.69MM | Early Stage Partners, Fletcher Spaght Ventures, Hatteras Venture Partners, Tgap Ventures, Venture Investors | |
Price per Share
$xx.xx
Shares Outstanding
14,172,418
Liquidation Pref Order
4
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Cumulative
Participating
Participating
Participation Cap
1000
Key Investors
Early Stage Partners, Fletcher Spaght Ventures, Hatteras Venture Partners, Tgap Ventures, Venture Investors
|